Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Holford

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology and Therapeutics|January 22, 2010
Dosing in childrenN Holford
Clinical Pharmacology and Therapeutics|July 21, 2012
Modeling helps in understanding antidepressantsN Holford
Clinical Pharmacology and Therapeutics|May 15, 2007
Time for quantitative clinical pharmacology: a proposal for a pharmacometrics curriculumN Holford, M O Karlsson
American Heart Journal|October 1, 1977
The digoxin concentration: before and after the factN Holford, L B Sheiner
Clinical Pharmacology and Therapeutics|July 25, 2014
The use of model-based tumor-size metrics to predict survivalB Ribba, N Holford, F Mentré
Clinical Pharmacokinetics|December 1, 1993
Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Population analysis of a randomised concentration controlled trialN Holford, Y Hashimoto, L B Sheiner
Clinical Pharmacology and Therapeutics|July 9, 2010
Clinical trial simulation: a reviewN Holford, S C Ma, B A Ploeger
The New Zealand Medical Journal|January 22, 1986
Slow-release theophylline (THEO-24)C B Mahood, R P Rothwell, N Holford
Clinical Pharmacokinetics|December 1, 1993
Theophylline target concentration in severe airways obstruction - 10 or 20 mg/L? A randomised concentration-controlled trialN Holford, P Black, R Couch, et al.
Circulation|July 1, 1980
Effects of antiarrhythmic drugs on atrioventricular conduction in patients with acute myocardial infarctionM M Scheinman, P Remedios, M D Cheitlin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|January 22, 2010
Dosing in childrenN Holford
Clinical Pharmacology and Therapeutics|July 21, 2012
Modeling helps in understanding antidepressantsN Holford
Clinical Pharmacology and Therapeutics|May 15, 2007
Time for quantitative clinical pharmacology: a proposal for a pharmacometrics curriculumN Holford, M O Karlsson
American Heart Journal|October 1, 1977
The digoxin concentration: before and after the factN Holford, L B Sheiner
Clinical Pharmacology and Therapeutics|July 25, 2014
The use of model-based tumor-size metrics to predict survivalB Ribba, N Holford, F Mentré
Clinical Pharmacokinetics|December 1, 1993
Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Population analysis of a randomised concentration controlled trialN Holford, Y Hashimoto, L B Sheiner
Clinical Pharmacology and Therapeutics|July 9, 2010
Clinical trial simulation: a reviewN Holford, S C Ma, B A Ploeger
The New Zealand Medical Journal|January 22, 1986
Slow-release theophylline (THEO-24)C B Mahood, R P Rothwell, N Holford
Clinical Pharmacokinetics|December 1, 1993
Theophylline target concentration in severe airways obstruction - 10 or 20 mg/L? A randomised concentration-controlled trialN Holford, P Black, R Couch, et al.
Circulation|July 1, 1980
Effects of antiarrhythmic drugs on atrioventricular conduction in patients with acute myocardial infarctionM M Scheinman, P Remedios, M D Cheitlin, et al.
Pageof 2